Fact CheckerSign in

NCT06013072Completed

Pre-probiotic Supplementation for Post-covid Fatigue Syndrome

The Effects of 3-month Supplementation With a Pre-probiotic on Patient- and Clinician-reported Outcomes, and Brain Tissue Metabolism in Patients With Post-covid Fatigue Syndrome: a Placebo-controlled Randomized Clinical Trial

Source: ClinicalTrials.gov · Last updated 6 Feb 2024

Brief summary (registry, in English)

The goal of this randomized controlled double-blind parallel-group interventional trial is to evaluate the effects of of dietary supplementation with a pre-probiotic on patient- and clinician-reported outcomes, and brain tissue metabolism in patients with post-covid fatigue syndrome.

Status (registry)
Completed
Study type
Interventional
Enrollment
32 (actual)
First submitted
25 Aug 2023
Start date
1 Oct 2022
Primary completion date
31 Dec 2023
Lead sponsor
University of Novi Sad, Faculty of Sport and Physical Education
NCT number
NCT06013072

What you commit to

  • Study type: Interventional
  • Participants enrolled: 32
  • From 1 Oct 2022 to the primary completion date, 31 Dec 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Medication or supplement which can impact the gut microbiome, including: antibiotics, antimicrobials, or antifungals in the two months

Other illness

  • Other pulmonary and cardiovascular conditions
  • History of dietary supplement use during the past 4 weeks
  • Organic gastrointestinal (GI) disorders such as inflammatory bowel disease, coeliac disease, eosinophilic disorders, or current infection of the GI tract.
  • Bowel surgery or short bowel syndrome.

Other

  • Probiotic or prebiotic supplements in the last 4 weeks

Who the study is looking for

  • Age 18 - 65 years
  • Covid-19 positive test within last 3 months (as documented byvalid PCR or antigentest
  • Moderate-to-severe fatigue (20-MFI test total score \> 43.5)
  • At least one of additional covid-19 related symptoms (anosmia,ageusia,breathingdifficulties,lungpain, body aches, headaches, difficulties concentrating etc.)

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Applied Bioenergetics Lab at Faculty of Sport and PE
Coordinator of this site? Confirm its status
Novi SadSerbiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.